Bioanalysis of emixustat (ACU-4429) in whole blood collected with volumetric absorptive microsampling by LC

Bioanalysis of emixustat (ACU-4429) in whole blood collected with volumetric absorptive microsampling by LC–MS/MS

Published:2015-09 Issue:16 Volume:7 Page:2071-2083
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Miao Zhixin¹,Farnham James G¹,Hanson Glenn¹,Podoll Terry²,Reid Michael J²

Affiliation:

1. Covance Laboratories, Inc., 3301 Kinsman Blvd., Madison, WI 53704, USA

2. Acucela, Inc., 21720 23rd Drive SE, Suite 120, Bothell, WA 98021, USA

Abstract

Background: A method to quantify emixustat (an investigational drug agent) in human blood collected using volumetric absorptive microsampling (VAMS) could be more practical for sample collection at sites with limited facilities for processing and storage of plasma. Methods: A LC–MS/MS method was developed and evaluated for accuracy and precision, linearity, carryover, selectivity, recovery, matrix effects, hematocrit effects and stability. Results: Core validation parameters met acceptance criteria within the normal ranges of hematocrit levels for adults (30–55%). Stability of emixustat in blood collected with and without anticoagulant (NaF/KOx) on the VAMS device at ambient, refrigerated and frozen conditions was established. Conclusion: The method has been validated and is suitable for the bioanalysis of emixustat in human blood collected by VAMS.

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Link

http://www.future-science.com/doi/pdf/10.4155/bio.15.125

Reference17 articles.

1. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection

2. EBF recommendation on the validation of bioanalytical methods for dried blood spots

3. Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium

4. Neoteryx LLC. Extraction guidelines for the Mitra™ (RUO) microsampling device. Technical Brief (2014). www.phenomenex.com.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface-Enhanced Raman Spectroscopy Combined with Multivariate Analysis for Fingerprinting Clinically Similar Fibromyalgia and Long COVID Syndromes;Biomedicines;2024-06-28

2. Validation of low-volume sampling devices for pharmacokinetic analysis: technical and logistical challenges and solutions;Bioanalysis;2023-10-19

3. Volumetric Absorptive Microsampling in the Analysis of Endogenous Metabolites;Metabolites;2023-09-26

4. Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review;Molecules;2023-08-14

5. Applications of Volumetric Absorptive Microsampling Technique: A Systematic Critical Review;Therapeutic Drug Monitoring;2023-03-06